China (Mainland)
Erigeron breviscapus Extract Scutellarin Breviscapine CAS NO.116122-36-2
- FOB Price: USD: 1.00-1.00 /Metric Ton Get Latest Price
- Min.Order: 1 Kilogram
- Payment Terms: L/C,T/T,
- Available Specifications:
1(1-10)Metric Ton
- Product Details
Keywords
- Breviscapine
- Scutellarin
- Erigeron breviscapus Extract
Quick Details
- ProName: Erigeron breviscapus Extract Scutellar...
- CasNo: 116122-36-2
- Molecular Formula: C21H18O12
- Appearance: Light yellow or off white powder
- Application: platelet?aggregation
- DeliveryTime: 2 days after payment
- PackAge: Inside is two plastic bag, Outside is ...
- Port: Shanghai
- ProductionCapacity: 1000 Metric Ton/Day
- Purity: 1%-98%
- Storage: Inside is two plastic bag, Outside is ...
- LimitNum: 1 Kilogram
- Plant of Origin: erigeron breviscapus extract
- Testing Method: UV/HPLC
- Product Ecification: 1%,98%(HPLC)
- Heavy Metal: Less than 5PPM
- Voluntary Standards: CP
Superiority
Function
1, to improve cerebral blood circulation, increase cerebral blood flow, reducing vascular resistance, increase the permeability of the blood-brain barrier, conducive to the prevention and treatment of cerebral thrombosis formation.
2, the expansion of the coronary artery and peripheral vascular, reducing myocardial oxygen consumption, to increase nutrition myocardial blood flow, improve myocardial microcirculation.
3, lower cholesterol, reduce high blood viscosity, platelet aggregation.
4, increasing the phagocytic function of the liver reticuloendothelial cells and macrophages, increased blood CAMP content, improve the immune system.
5, inhibition of intravascular coagulation, fibrinolysis promoting, reducing fibrinogen, and anti-tied thrombolysis.
Applications :
healthcare product and mendcines and drugs
Details
Breviscapine Descriptions
1.Erigeron breviscapus Extract Breviscapine powder
2.Specification: Breviscapine 80% 95% 98%
3.Test Method: HPLC
4.Cas. No.: 116112-36-2
5.ExtractMolecular Formula: C21H18O12
6.Molecular Weight: 462.4
7.Extract Part: flower
Specifications
|
CAS NO. |
116122-36-2 |
|
Molecular Weight |
908.723 |
|
Appearance |
Yellow powder |
|
Odor & Taste |
Characteristic |
|
Assay(HPLC) |
Breviscapine 90%,95%,98% |
|
Loss on Drying |
≤5.0% |
|
Ignition Residue |
≤5.0% |
|
Sieve Analysis |
≥100mesh |
|
Extract Solvent |
Ethanol |
|
Residual Solvent |
≤0.5% |
|
Heavy Metal |
≤10ppm |
|
Total Plate Count |
<1000cfu/g |
|
Yeast & Mold |
<100cfu/g |
|
E.Coil |
Negative |
|
Salmonella |
Negative |
|
Storage |
Store in cool & dry place. Keep away from strong light and heat. |
About Breviscapine Source
This product belongs to Erigeron reviscapus flavonsides extracted from Erigeron breviscapus (Vant.) Hand. ¨CMazz. Pharmacologydilating brain blood vessels, reducing obstruction of brain vessels, increasing blood flow in brain, improving microcirculation, and showing antiplatelet aggregation. According to the above functions, we have researched and manufactured Brevicapine tablet. It can treat paralysis resulting from cerebral vascular vascular occlusion and brain bleeding. IndicationsApplication to apoplexy, angina pectoris and coronary heart disease.